Publications by authors named "Renske Wever"

Claim this Profile
C
Correction: Enhanced Risk Stratification for Sentinel Lymph Node Biopsy in Head and Neck Melanoma Using the Merlin Assay (CP-GEP).
Ani Pazhava, Wesley Y Yu, Frank Z Jing, Sheena Hill, Bethany R Rohr, Renske Wever

Ann Surg Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Enhanced Risk Stratification for Sentinel Lymph Node Biopsy in Head and Neck Melanoma Using the Merlin Assay (CP-GEP).
Ani Pazhava, Wesley Y Yu, Frank Z Jing, Sheena Hill, Bethany R Rohr, Renske Wever

Ann Surg Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Risk Stratification for Sentinel Lymph Node Biopsy in Head and Neck Melanoma Using the Merlin Assay (CP-GEP).
Ani Pazhava, Wesley Y Yu, Frank Z Jing, Sheena Hill, Bethany R Rohr, Renske Wever

Ann Surg Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of stage I/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP).
Teresa Amaral, Tobias Sinnberg, Eftychia Chatziioannou, Heike Niessner, Ulrike Leiter, Renske Wever

Eur J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic models predicting non-sentinel lymph node metastasis in cutaneous melanoma patients: Are they useful for patients with a single positive sentinel node?
Barbara Rentroia-Pacheco, Félicia J Tjien-Fooh, Enrica Quattrocchi, Ajdin Kobic, Renske Wever

J Surg Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-Resolved Metagenomics of a Photosynthetic Bioreactor Performing Biological Nutrient Removal.
Elizabeth A McDaniel, Renske Wever, Ben O Oyserman, Daniel R Noguera, Katherine D McMahon

Microbiol Resour Announc· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.
Alexander M M Eggermont, Domenico Bellomo, Suzette M Arias-Mejias, Enrica Quattrocchi, Sindhuja Sominidi-Damodaran, Renske Wever

Eur J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis